免疫球蛋白產品市場：按類型（IGA、IGD、IGE）、ROA（IMIG、IVIG、SCIG）、按用途- 2023-2030 年全球預測

預計2023年全球免疫球蛋白產品市場將達138.6億美元，年複合成長率為11.19%，預計2030年將達292.4億美元。

FPNV定位矩陣

FPNV定位矩陣對於評估全球免疫球蛋白產品市場至關重要。透過檢查業務策略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使您能夠根據您的特定需求做出明智的資訊。這種進階分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市佔率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、累積和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通膨的累積影響。

5.競爭評估與資訊：對主要企業的市場佔有率、策略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評估。

6. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 免疫球蛋白產品的全球市場規模及預測為何？

2.在預測期內，COVID-19 對全球免疫球蛋白產品市場的阻礙因素和影響為何？

3. 在預測期內，全球免疫球蛋白產品市場需要投資哪些產品/細分市場/應用/領域？

4. 你們在全球免疫球蛋白產品市場的競爭策略是什麼？

5. 全球免疫球蛋白產品市場的技術趨勢和法律規範是什麼？

6. 全球免疫球蛋白產品市場主要供應商的市佔率為何？

7. 哪些型態和策略性措施被認為適合進入全球免疫球蛋白產品市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

• 市場動態
  • 促進因素
    • 免疫缺陷疾病增加
    • 世界各地的老年人口正在增加
    • 免疫球蛋白產品的採用迅速增加
  • 抑制因素
    • 免疫球蛋白產品高成本且副作用大
  • 機會
    • 免疫球蛋白的持續研究和開發活動
    • 新型和先進的免疫球蛋白產品介紹
  • 任務
    • 治理機構對產品核可嚴格的規則和規範
• 市場趨勢
• COVID-19 的累積影響
• 俄羅斯-烏克蘭衝突的累積影響
• 高通膨的累積效應
• 波特五力分析
• 價值鍊和關鍵路徑分析
• 法律規範
• 客戶客製化

第6章 免疫球蛋白產品市場：依類型

• 伊賀
• IGD
• IGE
• IGG
• IGM

第7章 按 ROA 分類的免疫球蛋白產品市場

• IMIG
• IVIG
• SCIG

第8章 免疫球蛋白產品市場：依用途

• CIDP
• CLL
• 先天性愛滋病
• 低丙種球蛋白血症
• ITP
• 免疫缺陷症
• 川崎病
• 多灶性運動神經病變
• 重症肌無力

第9章 美洲免疫球蛋白產品市場

• 阿根廷
• 巴西
• 加拿大
• 墨西哥
• 美國

第10章 亞太免疫球蛋白產品市場

• 澳洲
• 中國
• 印度
• 印尼
• 日本
• 馬來西亞
• 菲律賓
• 新加坡
• 韓國
• 台灣
• 泰國
• 越南

第11章歐洲、中東和非洲免疫球蛋白產品市場

• 丹麥
• 埃及
• 芬蘭
• 法國
• 德國
• 以色列
• 義大利
• 荷蘭
• 奈及利亞
• 挪威
• 波蘭
• 卡達
• 俄羅斯
• 沙烏地阿拉伯
• 南非
• 西班牙
• 瑞典
• 瑞士
• 土耳其
• 阿拉伯聯合大公國
• 英國

第12章競爭形勢

• FPNV定位矩陣
• 市佔率分析：主要企業
• 競爭情境分析：主要企業

第13章上市公司名單

第14章附錄

• 討論指南
• 關於許可證和定價

The Global Immunoglobulin Product Market is forecasted to grow significantly, with a projected USD 13.86 billion in 2023 at a CAGR of 11.19% and expected to reach a staggering USD 29.24 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Immunoglobulin Product Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Immunoglobulin Product Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Type, market is studied across IGA, IGD, IGE, IGG, and IGM. The IGD is projected to witness significant market share during forecast period.

Based on ROA, market is studied across IMIG, IVIG, and SCIG. The IVIG is projected to witness significant market share during forecast period.

Based on Application, market is studied across CIDP, CLL, Congenital AIDS, Hypogammaglobulinemia, ITP, Immunodeficiency Diseases, Kawasaki Disease, Multifocal Motor Neuropathy, and Myasthenia Gravis. The Multifocal Motor Neuropathy is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 35.36% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Immunoglobulin Product Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Immunoglobulin Product Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Immunoglobulin Product Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Immunoglobulin Product Market?

4. What is the competitive strategic window for opportunities in the Global Immunoglobulin Product Market?

5. What are the technology trends and regulatory frameworks in the Global Immunoglobulin Product Market?

6. What is the market share of the leading vendors in the Global Immunoglobulin Product Market?

7. What modes and strategic moves are considered suitable for entering the Global Immunoglobulin Product Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Immunoglobulin Product Market, by Type, 2022 vs 2030
• 4.3. Immunoglobulin Product Market, by ROA, 2022 vs 2030
• 4.4. Immunoglobulin Product Market, by Application, 2022 vs 2030
• 4.5. Immunoglobulin Product Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in the Cases of Immunodeficiency Diseases
    • 5.1.1.2. Growing Geriatric Population Around the World
    • 5.1.1.3. Surge in the Adoption of Immunoglobulin Products
  • 5.1.2. Restraints
    • 5.1.2.1. High Cost and Adverse Effects of the Immunoglobulin Products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Research and Development Activities in the Immunoglobulin
    • 5.1.3.2. Introduction of New & Advanced Immunoglobulin Products
  • 5.1.4. Challenges
    • 5.1.4.1. Strict Rules and Norms of Governing Bodies for Product Approval
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Immunoglobulin Product Market, by Type

• 6.1. Introduction
• 6.2. IGA
• 6.3. IGD
• 6.4. IGE
• 6.5. IGG
• 6.6. IGM

7. Immunoglobulin Product Market, by ROA

• 7.1. Introduction
• 7.2. IMIG
• 7.3. IVIG
• 7.4. SCIG

8. Immunoglobulin Product Market, by Application

• 8.1. Introduction
• 8.2. CIDP
• 8.3. CLL
• 8.4. Congenital AIDS
• 8.5. Hypogammaglobulinemia
• 8.6. ITP
• 8.7. Immunodeficiency Diseases
• 8.8. Kawasaki Disease
• 8.9. Multifocal Motor Neuropathy
• 8.10. Myasthenia Gravis

9. Americas Immunoglobulin Product Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Immunoglobulin Product Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Immunoglobulin Product Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing

LIST OF FIGURES

• FIGURE 1. IMMUNOGLOBULIN PRODUCT MARKET RESEARCH PROCESS
• FIGURE 2. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2022 VS 2030
• FIGURE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
• FIGURE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2022 VS 2030 (%)
• FIGURE 6. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. IMMUNOGLOBULIN PRODUCT MARKET DYNAMICS
• FIGURE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. IMMUNOGLOBULIN PRODUCT MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. IMMUNOGLOBULIN PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 5. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IGM, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 11. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMIG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IVIG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY SCIG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CIDP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CLL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY CONGENITAL AIDS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY HYPOGAMMAGLOBULINEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ITP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY IMMUNODEFICIENCY DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY KAWASAKI DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MULTIFOCAL MOTOR NEUROPATHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 36. CANADA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 53. CHINA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 54. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 56. INDIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 58. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 59. INDONESIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 62. JAPAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 65. MALAYSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 68. PHILIPPINES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 71. SINGAPORE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 74. SOUTH KOREA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 77. TAIWAN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 80. THAILAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 83. VIETNAM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 90. DENMARK IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 93. EGYPT IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 96. FINLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 99. FRANCE IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 102. GERMANY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 105. ISRAEL IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 107. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 108. ITALY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 111. NETHERLANDS IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 114. NIGERIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 117. NORWAY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 119. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 120. POLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 123. QATAR IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 125. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 126. RUSSIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 129. SAUDI ARABIA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 132. SOUTH AFRICA IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 135. SPAIN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 138. SWEDEN IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 141. SWITZERLAND IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 143. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 144. TURKEY IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 147. UNITED ARAB EMIRATES IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 149. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY ROA, 2018-2030 (USD MILLION)
• TABLE 150. UNITED KINGDOM IMMUNOGLOBULIN PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. IMMUNOGLOBULIN PRODUCT MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 152. IMMUNOGLOBULIN PRODUCT MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 153. IMMUNOGLOBULIN PRODUCT MARKET LICENSE & PRICING